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Abstract . Activation of the EGF receptor tyrosine
kinase by ligand indirectly activates a series of other
cellular enzymes, including protein kinase C . To test
the hypothesis that phosphorylation of the EGF recep-
tor by protein kinase C provides an intracellular nega-
tive feedback loop to attenuate EGF receptor signaling,
we used scanning EM to follow the characteristic EGF-
induced retraction of lamellipodia and concomitant
cell shape changes . Wild type and mutant EGF recep-
tors were expressed in receptor-deficient NR6 cells.
The mutant receptors were prepared by truncation at
C' terminal residue 973 (c'973) to provide resistance
to ligand-induced down regulation that strongly atten-
uates receptor signaling and by replacement of threo-
nine 654 (T654) with alanine (A654) to remove the site
of phosphorylation by protein kinase C . Cells express-
complex network of growth stimulatory and growth
inhibitory factors provides environmental informa-
tion that regulates cell proliferation . Sufficient signal
strength is required to elicit cell proliferation while mecha-
nisms forattenuating signaling arenecessary tolimit inappro-
priate cell division . Posttranscriptional mechanisms that at-
tenuate signaling by ligand-activated EGF receptors include
down regulation and transmodulation . On ligand binding,
EGF receptors, which are diffusely distributed on the cell
surface, cluster in coated pits (Haigler et al ., 1978), un-
dergo internalization via a high affinity saturable endocytic
process (Lund et al ., 1990), and are ultimately degraded
(Stoscheck and Carpenter, 1984) . Mutant EGF receptors
that fail todown regulate in response to ligand activation dis-
play increased mitogenesis and transformation at low con-
centrations ofEGF (Chen et al ., 1989 ; Wells et al ., 1990),
emphasizing the consequences of loss of this attenuation
mechanism .
Other signaling pathways can decrease the ability ofEGF
to act . The most extensively characterized mechanism for
transmodulation oftheEGF receptor involves protein kinase
C. Activated protein kinase C catalyzes phosphorylation of
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ing WT and c'973 EGF receptors demonstrated char-
acteristic lamellipodial retraction after exposure to EGF,
with the non-down regulating c'973 EGF receptors re-
sponding more rapidly. Exposure of cells to TPA
blocked this response . Replacement of T614 by alanine
resulted in EGF receptors that were resistant to TPA .
Cells expressing the A654 mutation underwent more
rapid and more extensive morphologic changes than
cells with the corresponding T614 EGF receptor. In cells
expressing T654 EGF receptors, down regulation of pro-
tein kinase C resulted in more rapid and extensive
EGF-induced changes similar to those seen in cells ex-
pressing A614 EGF receptors . These data indicate that
activation of protein kinase C and subsequent phos-
phorylation of the EGF receptor at T654 lead to rapid
physiological attenuation of EGF receptor signaling .
the EGF receptor at threonine 654 (7'6-54 ) 1 (Hunter et al .,
1984), resulting in decreased affinity ofthe receptor forEGF
(Shoyab et al ., 1979 ; Lin et al ., 1986), decreased EGF-
stimulated protein tyrosine kinase activity (Cochet et al .,
1984 ; Friedman et al., 1984 ; Downward et al., 1985), and
inhibition of ligand-induced receptor internalization and
down regulation (Lund et al ., 1990) . Ligand activation of
EGF receptors also results in phosphorylation at 7'654
(Whiteley and Glaser, 1986 ; Decker et al ., 1990) . This
presumably results from EGF receptors activating phospho-
lipase C (Hepler et al ., 1987) and phospholipase D (Bes-
terman et al ., 1986 ; Wright et al ., 1990) to generate di-
acylglycerol (DAG), the endogenous activator of protein
kinaseC (Nishizuka, 1984) . It has been postulated that a sec-
ond EGF-dependent attenuation mechanism exists wherein
activation of the EGF receptor results in subsequent activa-
tion of protein kinase C and negative feedback attenuation
occurs via receptor phosphorylation at 7'654. Attenuation
mechanisms different from down regulation may be espe-
cially important under certain conditions . For example, the
activating ligands EGF, TGF-«, and myxovirus growth fac-
tors are synthesized as membrane precursors (Scott et al .,
1983) and are capable of acting at the cell surface (Brach-
mann et al ., 1989 ; Wong et al ., 1989 ; Anklesaria et al .,
1 . Abbreviations used in this paper : A654, alanine 654 ; DAG, diacylglyc-
erol ; SEM, scanning EM ; 7'654, threonine 654 ; PDGF, platelet-derived
growth factor; TPA, 12-o-tetradecanoylphorbol-13-acetate .
5331990) under conditions where receptor internalization does
not occur .
It has been difficult to directly examine the potential role
ofprotein kinase C in attenuating EGF-induced receptor re-
sponses. Ligand-induced receptor internalization and down
regulation have complicated attempts to assess other attenua-
tion mechanisms thatmay be operating . Down regulation oc-
curs rapidly and is a prolonged process, whereas rapid
recovery from protein kinase C-mediated inhibition occurs
because DAG is rapidly metabolized (Bishop and Bell,
1986), protein kinase C is down regulated (Collins and
Rozengurt, 1984 ; Ballester and Rosen, 1985) and phospha-
tases are activated (Cohen, 1989) . By using mutant EGF
receptors that are defective in ligand-induced internalization
anddown regulation, ithasbecomepossible to assess the ex-
istence of a protein kinase C-mediated negative feedback
loop initiated by ligand-activated EGF receptors. With scan-
ning EM (SEM), we have assessed cell morphology which
is a sensitive assay ofintegrated biological responses elicited
by EGF (Chinkers et al., 1981 ; Miyata et al., 1989) . In re-
sponse to EGF, membrane ruffling, lamellipodial retraction,
and "rounding up" occur ; these cytoskeletal changes are rap-
idly induced and involve disengagement of lamellipodia
from the underlying substrate. Actin and a-actinin are redis-
tributed in cells exposed to EGF (Schlessinger and Geiger,
1981) ; myosin, spectrin, ezrin, and fimbrin also show a reor-
ganization coincident with these shape changes (Bretscher,
1989) . Filopodia become more apparent during lamel-
lipodial retraction as attachment to the substrate is lost .
Eventually, the filopodia are subsumed as the cell becomes
increasingly rounded with blebs and ridges becoming the
most apparent features (Jackowski et al ., 1990) . We used
morphological changes in NR6 cell lines expressing wild
typeand mutant EGF receptors that contain alanine at resi-
due 654 (A654) to remove the site of protein kinase C phos-
phorylation (Lin et al ., 1986 ; Davis, 1988) and mutantEGF
receptors defective in ligand-induced internalization and
down regulation (c'973) (Chen et al ., 1989 ; Wells et al .,
1990) to critically examine the operation of this proposed
negative feedback pathway of signal attenuation in vivo .
MaterialsandMethods
EGFReceptor Constructions
Three independently derived cDNA clones of the human EGF receptor
were analyzed inparallel . Two clones, Gen (Ullrich et al ., 1984) andUCSD
(Lin et al., 1984), were isolated from A431 cells that have a 25-fold am-
plifiedEGF receptor gene. These were compared to a human placental iso-
late (A . W and J. M . Bishop, unpublished data) . Sequences covering the
entire coding region from nucleotide 167 to 3880 (numbered according
to U11rich et al ., 1984) were obtained using the dideoxynucleotide
chain-terminating reaction (Sanger et al ., 1977) . Reactions and gels were
run in parallel with primary sequences deduced at points of divergence .
Results are shown in Table 1 . Only three differences were found ; all oc-
curred in the third base position of codons and did not alter the predicted
amino acid sequence. This allowed use of mutants in the UCSD A431-
derived clone without the possibility of an A431-specific mutation con-
tributing to the responses that were observed .
Site-directed mutagenesis was used to produce various EGF receptor
mutants . First, the threonine at amino acid 654 was replaced by an alamne
residue (Lin etal ., 1986) ; second, theEGF receptor was truncated at amino
acid 973 (c°973) by the incorporation of an amber codon followed by a
HindUI site (Chen et al ., 1989), yielding a receptor that fails to undergo
ligand-induced internalization and down regulation . The A651 variant ofthe
c'973 mutant was constructed by replacing the C' terminus from the Bg1II
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site at nucleotide 2951 ofthe WT A65a mutant with the corresponding frag-
mentofthec973 mutant . Allconstructions were resequenced in theregions
of mutation and in the juxtamembrane region.
Generation ofEGFReceptor-Expressing Cells
The EGF receptor constructions were cloned into a Moloney murine leuke-
mia virus-derived mammalian expression vector in the gag position (Wells
and Bishop, 1988) . This vector contains the neomycin-phosphotransferase
gene in the env position . The constructions were introduced into NR6 cells,
a 3T3 derivative that lacks endogenous EGF receptors (Pruss and Hetsch-
man, 1977), by the lipofectin reagent (Bethesda Research Laboratories,
Bethesda, MD) and by retruviral infection. Cells were maintained at 37°C,
8% COZ, and >60% humidity in MEMce supplemented with 10% FBS and
10 mM Hepes (pH 7.4) . Stable, polyclonal lines consisting of more than
20 colonies each were established and maintained in complete media sup-
plemented with the neomycin analog G418 (400 pg/ml, Gibco Laborato-
ries, Grand Island, NY) . Clonal lines were obtained by subcloning from
these lines at limiting dilution . Expression of EGF receptors was assayed
by specific binding of I'll-EGF to the cells (Chen et al ., 1989) . Function-
ing of the receptors was assessed by ligand-induced tyrosine kinase activa-
tion measured using Western blotting of whole cell extracts with 125j
labeled monoclonal anti-phosphotyrosine antibody PY20 (Glenney et al .,
1988), EGF-dependent incorporation of 3H-thymidine into DNA, and cell
growth . Two series oflines were isolated, one expressing -100,0001igand-
binding sites per cell and a second expressing -15,0001igand-binding sites
per cell . In all experiments the cells expressing either high or low numbers
of receptors behaved identically.
Analysis ofEGFReceptor Distribution
by Fluorescence-activated Cell Scanning
andImmunocytochemistry
For fluorescence-activated cell scanning analysis, cells were dissociated
from their substrate with EDTA, fixed with 3.7% paraformaldehyde, and in-
cubated with a monoclonal mouse antibody directed against the external do-
main of the EGF receptor (528 IgG) at 37°C for 30 min . After washing,
cells were incubated with goat anti-mouse immunoglobulin linked to
phycoerythrin for a further 30 min at 37°C. Analysis was carried out on
groups of 10,000 cells in a FACScanner (Becton Dickinson & Co ., Moun-
tain View, CA) ; data were analyzed with the accompanying LYSYS II soft-
warepackage. Histograms were taken through oneround ofsmoothing. For
indirect immunofluorescence, cells were fixed without dissociation and
stained as describedabove ; photographs weretaken with an optiphot micro-
scope (Nikon Inc ., Garden City, NY) at a magnification of 400x . Parental
NR6 cells lacking EGF receptors were analyzed in parallel to provide a con-
trol for background fluorescence .
SEM
For SEM analyses, cells were plated on half-inch glass coverslips and al-
lowed to adhere . Where indicated, TPA (10 nM ; Sigma Chemical Co., St .
Louis, MO) was added either 24 h or 10 min before the experiment . The
coverslips were transferred to warmed (37°C) media containing 10% dia-
lyzed FBS and EGF (50 nM) . Cells were maintained at 37°C until being
fixed in 2.5% bufferedglutaraldehyde (EMS, Fort Washington, PA) atroom
temperature for 1 h, postfixed in 2% OsO4 for 1 h, and dehydrated in abso-
lute ethanol . Peldri II (Ted Pella Inc., Irvine, CA), a sublimation dehydrant
was used in place of critical point drying (Kennedy et al ., 1989) . After 1 h
in a 1 :1 mix ofethanol and Peldri II, the samples were transferred to liquid
Peldri II, cooled to room temperature, and dried under vacuum for 12 h .
Table I . Comparison ofthe Sequence of Three Cloned
HumanEGFReceptor cDNAs
The entire coding sequence from nucleotide 167 to 3880 was obtained using
dideoxy chain terminating reactions . Reactions were run on parallel lanes of
sequencing gels and the points of difference verified . Differences at bases 738
and 2547 do not change the predicted amino acids . None of the clones contain
a HindIII restriction site at 1806 as indicated in the GenBank EGF receptor
sequence .
534
Base Placental Gen UCSD Effect
738 C C T L160 - L
1806 C C C No HindIII site
2547 G A A Q763 - QFigure 1. Scanning electron microscopic comparison ofthe rate and extent ofEGF-induced morphological changes in NR6 cells expressing
wild type and C' terminal truncated EGF receptors . Cells expressing either the wild type (WT) or the c'973 T654 receptor (c'973) were
exposed to 50 nMEGF for the indicated lengths of time. The cells were subsequently fixed, prepared, and visualized bySEM . Bar, 10 Am .
The coverslips were mounted on slotted specimen holders and coated with
￿
Quantitation ofthe Relative Cross-SectionalArea of
-500 A Au . A scanning electron microscope (model 360 ; Cambridge In-
￿
Individual Cells struments, Cambridge, U.K .) was used to image the cells . Representative
individual cells were photographed at 2,500x magnification .
￿
To quantitate the extent of morphological change of the cells under investi-
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￿
535Figure 2 . Expression ofc'973
T114 and c'973 A614 EGF re-
ceptors inNR6 cells . Cells ex-
pressing either c'973 T614 or
c'973A654EGF receptors were
analyzed by indirect immuno-
fluorescence and by fluores-
cence flow cytometry to ascer-
tain expression of receptors.
Cells were stained using the
mouse mAb 528 IgG directed
against the EGF receptor and
visualized using phycoeryth-
rin-conjugatedgoat anti-mouse
Ig antibody.
gation, ten random individual cells were followed throughout the course of
￿
were pooled for calculation of changes in cross-sectional area and analysis
a 9-min treatment with EGF . Cells were plated onto glass coverslips 2 d
￿
using I test .
before the experiment . TPA (10 nM) was addedto the media ofselected cov-
erslips on the day before the experiment . They were then transferred to a
￿
Results
microscope stage equilibrated to 37°C and photographed ; EGF was added
to a final concentration of 50nM and photographs were taken ofthe same
￿
C Terminal TlruncatedEGFReceptors Elicit a More
field of cells at 3, 6, and 9 min . Maximum cross-sectional area of the cells
￿
RapidChange in Cell Morphology
in the plane parallel to adherence was calculated . Experiments were per-
formed pairwise, and were reproduced . Data from several experiments
￿
EGF-induced morphological changes were compared be-
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536Figure 3 Effects of the phorbol ester TPA on EGF-induced morphologic changes in cells expressing T654 compared to A654 EGF recep-
tors . NR6 cells expressed EGF receptors truncated after amino acid 973 and having either a threonine residue (c'973 T65°) or an alanine
residue (c'973 A65°) at position 654 . These cells were either mock treated (no tx), exposed to 50 nM EGF for 10 min (EGF), or to 10
nM TPA for 10 min followed by 50 nM EGF for 10 min (TPA-EGF) . Bar, 10 tim .
tween cells expressing wild type and truncated c'973 T654
EGF receptors (Fig . 1) . Cells expressing wild type EGF re-
ceptors began to show lamellipodial retraction by 10 min of
exposure to 50 nM EGF, but a full response required more
than 1 h . Cells expressing c'973 T654 EGF receptors behaved
in a qualitatively similar manner, but retracted more rapidly.
One minute after addition of EGF, lamellipodial retraction
was evident, and there was an increase in thenumber offilo-
podia . These changes progressed at 5 min and by 10 min the
c'973 T654 cells were rounded up with striking morphologi-
cal alterations . The extent of morphological alteration at 100
min appeared similar for cells expressing the two EGF re-
ceptors. Because the time course of morphological changes
in cells expressing wild type receptors overlaps the time
course of ligand-induced receptor internalization and down
Welsh et al . Feedback Inhibition ofEGFReceptor Signaling
regulation (Wiley and Cunningham, 1982 ; Glenney et al.,
1988 ; Lund et al., 1990), cells expressing c'973 receptors
were used in subsequent studies to investigate signal atten-
uation by mechanisms distinct from down regulation . The
c'973 EGF receptor does not undergo signal attenuation by
ligand-induced down regulation (Chen et al ., 1989 ; Wells et
al ., 1990), making it more feasible to isolate other modes
ofsignal attenuation . The more rapid and extensive morpho-
logical response ofcells expressing c973 EGF receptors pre-
sumably results from enhancedEGF-stimulatedproteintyro-
sine kinase activity (Walton et al ., 1990) .
TPA Inhibits EGF-inducedMorphological Changes in
Cells Expressing TsN butNotA 6NEGFReceptors
The threonine at amino acid 654 (T65°) was changed to ala-
537nine (A65°) to remove a major site of receptor transmodula-
tion by protein kinase C . Polyclonal lines of NR6 cells ex-
pressing either the 0973 T654 or 0973 A654 EGF receptor
construction were established . Receptor expression in these
lines was assessed to determine whether the reactions to li-
gand observed in a subset ofthese cells would be representa-
tive of the whole population . Immunofluorescence staining
of both lines revealed that all cells expressed EGF receptor
protein on the cell surface as an apparent homogenous popu-
lation (Fig. 2) . Parental NR6 cells served as a negative con-
trol (data not shown) . Greater than 98% ofthe cells were rec-
ognized by the mAb to the EGF receptor when quantitated
by flow cytometry . Comparison of the relative fluorescence
of the two cell lines revealed a greater number of receptors
and a somewhat broader distribution in T614 than A654 EGF
receptors . Scatchard analysis confirmed this observation
with Kn = 1 .9 t 0.2 and 1.9 t 0.3 nM and B. = 1.2 x
105 and 4.3 x 104 receptors cell- ' in cells expressing 0973
T654 and 0973 A654 EGF receptors, respectively. Biphasic
components ofEGF binding are not included in these data
because only a small number ofhigh affinity EGF receptors
were present . Comparison of either data set to the back-
ground fluorescence of the untransfected NR6 parental cell
line indicated therewas no detectable subpopulation lacking
EGF receptors within the 0973 T654 or 0973 A654 recep-
tor-expressing cell lines .
Fig . 3 shows that 10 min of EGF treatment induced
significant morphological changes in NR6 cells expressing
both 0973 T654 and 0973 A654 EGF receptors . After 10 min
of exposure to EGF, the extent of morphological retraction
was significantly greater in cells expressing A614 compared
to T654 receptors . When cells were treated with 10 nM TPA
for 10 min before treatment with EGF for 10 min, the EGF-
induced morphological change was largely blocked in cells
expressing T614 receptors . In contrast TPA failed to block
the striking lamellipodial retraction, ruffling and rounding
up of cells expressing A654 EGF receptors . Replacement of
the single protein kinase C phosphorylation site at T654 with
alanine thus completely abolished the inhibitory effect of
TPA . The degree of TPA inhibition parallels the degree of
inhibition by TPA of EGF-induced protein tyrosine kinase
activity (Fig . 4) . In cells expressing either 0973 T654 or
0973 A654 EGF receptors, EGF rapidly increased tyrosine
phosphorylation of several cellular proteins . Treatment with
10 nM TPA for 10 min markedly decreased EGF-stimulated
tyrosine phosphorylation of proteins in cells expressing
0973 T654 EGF receptors . In contrast TPA failed to affect
EGF-stimulated protein tyrosine phosphorylation in cells ex-
pressing 0973 A654 EGF receptors .
Cells ExpressingEGF Receptors Lacking a
Protein KinaseC Phosphorylation Site at Residue
654 RespondMore Rapidly and Extensively to EGF
If endogenously activated protein kinase C attenuates EGF
receptor signaling, receptors that lack a feedback phos-
phorylation site would be expected to respond more rapidly
and more extensively to EGF. The more extensive morpho-
logical change with EGF in cells expressing A654 compared
to T654 receptors at 10 min (Fig . 3) suggested this was oc-
curring . To examine this more closely, we compared the
time-dependent extent of morphological changes in cells ex-
pressing T654 and A654 EGF receptors . Fig . 5 shows that, on
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Figure 4 . Effect ofTPA on EGF-stimulated tyrosine kinase activity
of T654 compared to A654 EGF receptors truncated at residue 973 .
NR6 cells (-5 x 105 ) expressing the indicated receptors were ex-
posed to either media (nt), 10 nM EGF for 10 min (E), or 10 nM
TPA for 10 min followed byEGF (TIE) . The cells were then lysed
in situ by the addition of hot Laemmli sample buffer and separated
by 7.5% SDS-PAGE . The proteins were transferred to nitrocellu-
lose. An 1251-labeled mAb directed against phosphotyrosine was
used to detect phosphotyrosine-containing proteins . c'973 T654,
receptor truncated after amino acid 973, with a threonine residue.
c'973 A634, receptor truncated after amino acid 973, with an ala-
nine residue .
exposure to EGF, the cytoskeletons ofboth cells rearrange as
demonstrated by lamellipodial retraction and increases in
apparent height at various points along the cell margin . The
change in morphology was more extensive in cells express-
ing A654 compared to T654 EGF receptors at each of the time
points examined (3, 6, and 9 min after addition of 50 nM
EGF) . These results, which show that the rate and extent of
EGF-induced morphological change is greater in cells ex-
pressing A654 receptors than in those expressing T654 recep-
tors, suggest this mutation removes an inhibitory constraint .
To quantitate the morphological changes observed with
SEM, individual cells were followed throughout the time
course ofEGF treatment by viewing and photographing ran-
domly selected fields at low power (200x) . When a cell
retracts, the cross-sectional area parallel to the surface of at-
tachment decreases . The cross-sectional area of individual
cells was therefore measured at 3-min intervals after EGF
addition . Fig. 6 shows that the rate and extent of decrease
in cross-sectional area was significantly greater for cells ex-
pressing 0973 A654 than 0973 T654 EGF receptors . The
changes observed withSEM are thus quantitative and repre-
sentative of the entire population . The greater decrease in
cross-sectional area in response to EGF in 0973 A654 EGF
538Figure5 . Time course of lamellipodial retraction in cells expressing Tes4 or A654 EGFreceptors . Cells expressed EGF receptors truncated
afteramino acid 973 andhad either a threonine residue (c'973 T654) or an alanine residue (c'973 A65a) at position 654. They were exposed
to 50 nM EGF for the indicated lengths of time and processed for SEM . Bar, 10 pm .
Welsh et al . Feedback Inhibition ofEGFReceptor Signaling
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Figure 6. Cell retraction in response to EGF. NR6 cells, expressing
the 0973 EGF receptor with either T or A at residue 654, were
plated on coverslips. These were treated with 50 nM EGE Random
cells were followed individually at 3-min intervals by light micros-
copy at 200x magnification. The cross-sectional area of each cell
was measured and scored as a percent of the area in the untreated
state. o, NR6 cells expressing the T654 EGF receptor; a, the same
cells after 24-h exposure to 10 nM TPA; o, NR6 cells express-
ing the A654 EGF receptor; A, the same cells after 24-h exposure
to 10 nM TPA . Results are mean t standard error ofmeans of 10
to 30 cells. **, P < 0.001 with respect to cells expressing 0973
A654 EGF receptors and to TPA-treated cell expressing either re-
ceptor.
receptor-expressing cells occurred despite a lower concen-
tration of receptors compared to cells expressing 0973 T654
EGF receptors.
Analogous to removal of the T654 phosphorylation site in
the EGF receptor, down regulation of protein kinase C by
prolonged exposure of cells to TPA should relieve feedback
inhibition via this enzyme. Exposure of NR6 cells to 10 nM
TPA for 24 h reduced protein kinase C mass and activity
more than 90 % (data not shown) similar to that which occurs
in parental 3T3 cells(Collins and Rozengurt, 1984; Ballester
and Rosen, 1985) . Cells expressing either 0973 T654 or A654
EGF receptors were exposed to 10 nM TPA for 24 h and then
treated with EGF . The response of 0973 A654 cells was not
affected by this treatment, confirming that protein kinase C
did not affect the response of these cells to EGF (Fig. 6) . In
contrast, as shown in Fig. 7, 24-h treatment with TPA sig-
nificantly enhanced EGF-stimulated morphological changes
in NR6 cells expressing 0973 T654 EGF receptors. In TPA-
pretreated cells morphological changes occurred earlier (3
and 6 min) and were more extensive. Quantitation of changes
in cross-sectional area confirmed that down regulation of
protein kinase C significantly enhanced morphological re-
sponses to EGF (Fig. 6) .
Activation of protein kinase C by the pharmacologic action
of phorbol esters or by DAG produced in response to other
hormones leads to decreased EGF receptor kinase activity
(Cochet et al., 1984; Friedman et al., 1984; Downward et
al., 1985; Lund et al., 1990). Transmodulation between sig-
naling pathways also occurs through less well-defined mech-
anisms. Platelet-derived growth factor, which increases
phosphorylation of the EGF receptor at T654, also causes a
decrease in high affinity EGF binding by a protein kinase
C-independent mechanism (Olashaw et al., 1986 ; Davis and
Czech, 1987). Interleukin 1 and tumor necrosis factor also
act independently of protein kinase C to transmodulate the
EGF receptor (Bird and Saklatvala, 1990). Palytoxin, a non-
TPA type tumor promoter, may act through mediation of so-
dium fluxes to decrease both high and low affinity compo-
nents of EGF binding (Wattenberg et al ., 1989) . A variety
of mechanisms thus exists to coordinate responses among
different signaling systems.
Similar mechanisms have been proposed to function as a
negative feedback loop to attenuate EGF receptor signaling.
King and Cooper (1986) demonstrated that some EGF recep-
tor molecules were both self phosphorylated on tyrosine
residues and at T654. Because prior phosphorylation at T654
inhibits EGF receptor self phosphorylation (Cochet et al .,
1984; Whiteley and Glaser, 1986; Decker et al., 1990; Lund
et al., 1990), these findings were interpreted as evidence for
a feedback loop that could attenuate further signaling by
ligand-activated receptors. It has been difficult to critically
test whether this proposed mechanism functions in vivo to
attenuate EGF-induced responses because of the rapid and
dominant effects of EGF-induced receptor internalization
and down regulation. In the present studies we have used
EGF receptor mutants defective in ligand-induced internal-
ization and down regulation, and have examined the early
morphologic alterations of lamellipodial retraction and
membrane ruffling that reflect cytoskeletal responses to
EGF . Several cytoskeletal proteins such as ezrin, spectrin
(Bretscher, 1989), and calpactin II (Campos-Gonzales et al.,
1990) are tyrosine phosphorylated in response to EGF and
are thought to be involved in the morphologic changes in-
duced by the growth factor.
Using 0973 T66° EGF receptors, TPA was shown to block
EGF-induced morphologic changes and to inhibit EGF-
stimulated protein tyrosine kinase activity in vivo. Replace-
ment of the single major protein kinase C phosphorylation
site with a non-phosphorylatable alanine residue rendered
the mutant EGF receptor completely refractory to the in-
hibitory effects of TPA. This strongly supports previous
findings that phosphorylation at T654 is the principal mecha-
nism through which protein kinase C inhibits EGF receptors
(Lin et al., 1986; Davis, 1988; Lund et al., 1990) .
Although NR6 cells expressing 0973 T654 and 0973 A654
EGF receptors exhibit similar time response curves for the
late response of EGF-stimulated cell growth (data not
shown), the morphologic response to EGF was both more
rapid and more extensive in cells expressing the A654 recep-
tor. The enhanced EGF stimulated lamellipodial retraction
and membrane ruffling in cells expressing 0973 A654 EGF
receptors suggested that a negative feedback restraint, oper-
ative at T654, was removed. This was further tested by down
regulating protein kinase C in cells expressing 0973 T654
receptors. When protein kinase C was down regulated, the
0973 T654 receptor-expressing cells responded more rapidly
540Figure 7 . Effect of down regulation of protein kinase C on the response to EGF by the c'973 Te54 EGF receptor-containing cells . NR6
cells expressing c'973 T 65° EGF receptors were grown in the absence (no TPA tx) or presence (TPA tx) of 10 nM TPA for 24 h . Cells
were subsequently exposed to 50 nM EGF for the indicated times . Bar, 10 jm .
Welsh et al . Feedback Inhibition ofEGFReceptor Signaling
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54 1and extensively, similar to those expressing c'973 A614
receptors . Thus, either elimination of the protein kinase C
phosphorylation site (Tss4) or down regulation of the en-
zyme led to a more rapid and extensive response to EGF To-
gether these results indicate that a feedback loop involving
protein kinaseC acts to attenuate EGF-stimulated responses .
The experimental system may underestimate the strength
of the negative feedback loop regulating EGF receptor sig-
naling . C' terminal truncation not only removes sequences
required for ligand-induced down regulation but also re-
moves sequences required for EGF-stimulated increases in
cytosolic [Cal+] (Chen et al., 1989) . The ability of ligand-
activated EGF receptors to increase inositol phosphate
production is also decreased by removal of C' terminal se-
quences (Q. C . Vega and G. N . Gill, unpublished observa-
tions) . This suggests that EGF may activate protein kinase
C by increasing DAG via mechanisms in addition to phos-
pholipase C--y activation . Wright et al . (1990) found that the
rise in DAG in response to EGF stimulation is in large part
because of hydrolysis of phosphatidylcholine, a process that
can occur rapidly (Besterman et al ., 1986) . They implicate
phospholipase D, which hydrolyzes phosphatidylcholine to
choline and phosphatidic acid, the latter being converted to
DAG . This receptor-mediated hydrolysis of phosphatidyl-
choline can lead to DAG production for the rapid activation
of protein kinase C (Slivka et al ., 1988) . As reported for
PDGF (Olashaw et al ., 1986; Davis and Czech, 1987), other
kinase pathways may also lead to phosphorylation at T6s4 .
Use of c'973 A6s4 EGF receptors cannot distinguish such
mechanisms, but the effects ofdown regulation ofprotein ki-
nase C suggest that protein kinase C is strongly involved in
EGF-induced receptor attenuation . If other kinases are in-
volved, their principal target appears to be T114 (Countaway
et al ., 1990 ; Heisermann et al ., 1990) . These morphological
data thus strongly support the hypothesis that protein kinase
C is involved in physiologic regulation ofEGF receptor sig-
naling .
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